cabozantinib,atezolizumab
roche
['contact-03', 'rcc,(-irccs),(-srcc),(-urcc)']
negative results of contact-03: no benefit in orr, pfs &amp; os and more toxicity. immediate io after io does not work in met rcc #asco23 
Oncólogo médico en @parctauli y Hospital de Barcelona. Vocal de la Junta Directiva de @sogug1. Wine lover. Life-enjoying!